Detect, Treat, Save - Driving a revolution in healthcare

Metfora’s innovative technology has the ability to detect serious and potentially fatal chronic diseases while they are still treatable, reducing patient mortality and improving quality of life.

Learn More
The burden of chronic disease

45% of Americans suffer from at least one chronic disease.1

The biological process of a chronic disease progresses within the body for decades, but most people only learn about their condition when the symptoms escalate and become troublesome. For many of these diseases, years of high-cost tests and invasive methods follow, and all too often patients get an incorrect diagnosis and consequently the wrong treatment.

What if there were a test that quickly recognized chronic diseases before the condition escalates?

Through our research, we are developing a technology that detects chronic diseases quickly and definitively.

1 An Empirical Study of Chronic Diseases in the United States, W Raghupathi, V Raghupathi, Int J Environ Res Public Health. 2018; 15(3): 431
Learn More
the metfora


The Metfora AI-based blood test is the diagnostic tool of the future, driving a shift in healthcare to early diagnosis and intervention, improving patient care and reducing unnecessary medical costs. The test analyzes circulating metabolites to detect disease-driven metabolic changes.  AI is used to extract these patterns which we term “metabolic fingerprints”.

A blood draw is performed during the annual exam or in response to symptoms

Circulating metabolites in the blood are analyzed using HPLC and mass spectrometry

“Metabolic fingerprints” are identified using algorithms developed by machine learning